Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22

Overview of attention for article published in Gene Therapy, January 1999

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

patent: 30 patents

Readers on

mendeley: 40 Mendeley

So far, Altmetric has seen 30 patents that reference this research output.

Modified peptide fragments of Cav-1 protein and the use thereof in the treatment of…

Grant US-12497431-B2

United States of America

16 Dec 2025

B1SP fusion protein therapeutics, methods, and uses

Grant US-12378301-B2

United States of America

05 Aug 2025

PEPTIDE FTTFTVT FOR USE IN TREATING FIBROSIS

Application EP-4438044-A2

European Patent Office

02 Oct 2024

Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of…

Grant US-11905336-B2

United States of America

20 Feb 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 26 additional patents.